Evidence map›Paper›PMID 38590437›Full record

ArticleFrontiers in cellular and infection microbiology2024

Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virus-infected patients.

Benjamin Koch, Mahmoud Shehata, Christin Müller-Ruttloff, Shady A Gouda, Nils Wetzstein, Sammy Patyna, Anica Scholz, Tobias Schmid, Ursula Dietrich, Christian Münch and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Benjamin KochDepartment of Internal Medicine 4, Nephrology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Mahmoud ShehataCenter of Scientific Excellence for Influenza Viruses, National Research Centre (NRC), Cairo, Egypt.
Christin Müller-RuttloffInstitute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.
Shady A GoudaInstitute for Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany.
Nils WetzsteinDepartment of Internal Medicine 2, Infectious Diseases, Goethe University Frankfurt, Frankfurt am Main, Germany.
Sammy PatynaDepartment of Internal Medicine 4, Nephrology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Anica ScholzInstitute of Biochemistry I, Goethe University Frankfurt, Frankfurt am Main, Germany.
Tobias SchmidInstitute of Biochemistry I, Goethe University Frankfurt, Frankfurt am Main, Germany.
Ursula DietrichInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.
Christian MünchInstitute for Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany.
John ZiebuhrInstitute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.
Helmut GeigerDepartment of Internal Medicine 4, Nephrology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Luis Martinez-SobridoTexas Biomedical Research Institute, Disease Intervention & Prevention (DIP) and Host Pathogen Interactions (HPI) Programs, San Antonio, TX, United States.
Patrick C BaerDepartment of Internal Medicine 4, Nephrology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Ahmed MostafaCenter of Scientific Excellence for Influenza Viruses, National Research Centre (NRC), Cairo, Egypt.
Stephan PleschkaInstitute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.
Goethe University Frankfurt · DEJustus-Liebig-Universität Gießen · DETexas Biomedical Research Institute · USGeorg Speyer Haus · DE

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing AntibodiesR01AI141607 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI DE FIGUEIREDO, PAUL, HAN, ARUM · 2019 to 2023
$3.4M
Dynamics of the protective vaccine-induced human influenza neuraminidase B cell responseR01AI145332 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KOBIE, JAMES J, MARTINEZ-SOBRIDO, LUIS · 2019 to 2022
$3.0M
NIAID NIH HHS 75N93021C00014NIAID NIH HHS R01 AI141607NIAID NIH HHS R01 AI145332
6 · The paper itself

Abstract

Introduction: Influenza A virus (IAV) infection can cause the often-lethal acute respiratory distress syndrome (ARDS) of the lung. Concomitantly, acute kidney injury (AKI) is frequently noticed during IAV infection, correlating with an increased mortality. The aim of this study was to elucidate the interaction of IAV with human kidney cells and, thereby, to assess the mechanisms underlying IAV-mediated AKI. Methods: To investigate IAV effects on nephron cells we performed infectivity assays with human IAV, as well as with human isolates of either low or highly pathogenic avian IAV. Also, transcriptome and proteome analysis of IAV-infected primary human distal tubular kidney cells (DTC) was performed. Furthermore, the DTC transcriptome was compared to existing transcriptomic data from IAV-infected lung and trachea cells. Results: We demonstrate productive replication of all tested IAV strains on primary and immortalized nephron cells. Comparison of our transcriptome and proteome analysis of H1N1-type IAV-infected human primary distal tubular cells (DTC) with existing data from H1N1-type IAV-infected lung and primary trachea cells revealed enrichment of specific factors responsible for regulated cell death in primary DTC, which could be targeted by specific inhibitors. Discussion: IAV not only infects, but also productively replicates on different human nephron cells. Importantly, multi-omics analysis revealed regulated cell death as potential contributing factor for the clinically observed kidney pathology in influenza.

Indexed as

Acute Kidney InjuryInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza, HumanOrthomyxoviridae InfectionsRegulated Cell DeathHumansInfluenza A Virus, H3N2 SubtypeKidneyProteomeVirus ReplicationProteomeacute kidney injurydistal tubular cellsinfluenza A virusproteomicsregulated cell deathtranscriptomics

Identifiers

PMID38590437
PMCPMC10999593
OpenAlexW4393153004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.